Search - tctmd.com

Displaying 41 - 60 of 195

Sort: Relevancy | Date

News Daily News

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

Shelley Wood

January 21, 2016

News Daily News

NSTEMI 患者早期有创干预优于延迟治疗

Michael O'Riordan

January 20, 2016

News Daily News

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Michael O'Riordan

January 20, 2016

News Daily News

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

Todd Neale

December 30, 2015

Presentation TCT 2015

NSTE-ACS Case Presentation: From Presentation Through Discharge

Presenter: Ajay J. Kirtane, Gary S. Mintz, Manish A. Parikh, Bo Xu, Qi Zhang

October 11, 2015

Presentation TCT 2015

NSTE-ACS: Risk Stratification and Treatment

Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman

October 11, 2015

News Daily News

Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary

Todd Neale

September 28, 2015

News Daily News

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

L.A. McKeown

September 21, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

News Industry News

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

September 10, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Yael L. Maxwell

September 02, 2015

News Conference News ESC 2015

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

L.A. McKeown

August 31, 2015

News Conference News ESC 2015

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Caitlin E. Cox

August 31, 2015

News Daily News

RITA 3的结果发布：对NSTE-ACS采取的常规侵入性策略在10年时失去优势

July 30, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

Presentation

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Presenter: Robert A. Henderson

July 29, 2015

Advertisement

Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS

NSTEMI 患者早期有创干预优于延迟治疗

Early Invasive Intervention Trumps Delayed Approach in NSTEMI Patients

Bioresorbable Scaffolds May Have Role in Spontaneous Coronary Artery Dissections

NSTE-ACS Case Presentation: From Presentation Through Discharge

NSTE-ACS: Risk Stratification and Treatment

Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Medicure Announces Filing of sNDA for New AGGRASTAT® Indication

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI

Novel Diabetes Drug Shows No Sign of Increasing Events in ACS Patients

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

RITA 3的结果发布：对NSTE-ACS采取的常规侵入性策略在10年时失去优势

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

RITA 3: 10-Year Mortality Outcome of Routine Invasive vs Selective Invasive Strategy in NSTE-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content